Evidence map›Paper›PMID 28631037›Full record

ArticleMedical molecular morphology2017

Inclusion bodies of aggregated hemosiderins in liver macrophages.

Hisao Hayashi, Yasuaki Tatsumi, Shinya Wakusawa, Ryota Shigemasa, Ryoji Koide, Ken-Ichi Tsuchida, Natsuko Morotomi, Tetsuji Yamashita, Kotaro Kumagai, Yukiya Ono and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hisao HayashiDepartment of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Japan. hhayashi@dpc.agu.ac.jp.
Yasuaki TatsumiDepartment of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Japan.
Shinya WakusawaDepartment of Medical Technology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ryota ShigemasaDepartment of Medical Technology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ryoji KoideDepartment of Medical Technology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ken-Ichi TsuchidaDiabetes Mellitus Center, Manda Memorial Hospital, Sapporo, Japan.
Natsuko MorotomiDepartment of Medicine, Moji City Hospital, Moji, Japan.
Tetsuji YamashitaYamashita Clinic, Matsuyama, Japan.
Kotaro KumagaiDigestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Yukiya OnoDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kazuhiko HayashiDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masatoshi IshigamiDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hidemi GotoDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ayako KatoDepartment of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Japan.
Koichi KatoDepartment of Medicine, Aichi Gakuin University School of Pharmacy, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemosiderin formation is a structural indication of iron overload. We investigated further adaptations of the liver to excess iron. Five patients with livers showing iron-rich inclusions larger than 2 µm were selected from our database. The clinical features of patients and structures of the inclusions were compared with those of 2 controls with mild iron overload. All patients had severe iron overload with more than 5000 ng/mL of serum ferritin. Etiologies were variable, from hemochromatosis to iatrogenic iron overload. Their histological stages were either portal fibrosis or cirrhosis. Inclusion bodies were ultra-structurally visualized as aggregated hemosiderins in the periportal macrophages. X-ray analysis always identified, in addition to a large amount of iron complexes including oxygen and phosphorus, a small amount of copper and sulfur in the mosaic matrixes of inclusions. There were no inclusions in the control livers. Inclusion bodies, when the liver is loaded with excess iron, may appear in the macrophages as isolated organella of aggregated hemosiderins. Trace amounts of copper-sulfur complexes were always identified in the mosaic matrices of the inclusions, suggesting cuproprotein induction against excess iron. In conclusion, inclusion formation in macrophages may be an adaptation of the liver loaded with excess iron.

Indexed as

AdultAgedCase-Control StudiesCation Transport ProteinsCopperFemaleFerroportinGene ExpressionHemochromatosisHemochromatosis ProteinHemosiderinHumansInclusion BodiesIronIron OverloadLiverCation Transport ProteinsCopperFerroportinHemochromatosis ProteinHemosiderinHFE protein, humanIronReceptors, TransferrinTFR2 protein, humanCopperHemochromatosisHemosiderinIronLiverMacrophage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.